Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia

X-linked hypophosphatemia (XLH) is characterized by lower extremity deformities that lead to bone and/or joint pain that result from decreased renal tubular reabsorption leading to hypophosphatemia caused by elevated levels of fibroblast growth factor 23 (FGF23). OBJECTIVE: Validate the use of SF-36...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruppe, Mary D., Zhang, Xiaoping, Imel, Erik A., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey S., Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Peacock, Munro, Carpenter, Thomas O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926842/
https://www.ncbi.nlm.nih.gov/pubmed/28326356
http://dx.doi.org/10.1016/j.bonr.2016.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926842/
https://www.ncbi.nlm.nih.gov/pubmed/28326356
http://dx.doi.org/10.1016/j.bonr.2016.05.004

Ejemplares similares